{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:05:29Z","timestamp":1761901529845,"version":"build-2065373602"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.msard.2020.102156","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T19:31:14Z","timestamp":1589657474000},"page":"102156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The Potential Immunoregulatory Roles of Vitamin D in Neuromyelitis Optica Spectrum Disorder"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7366-0796","authenticated-orcid":false,"given":"Yifan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2454-2173","authenticated-orcid":false,"given":"Desheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangtai","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2020.102156_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577168","article-title":"Serum AQP4-IgG level is associated with the phenotype of the first attack in neuromyelitis optica spectrum disorders","volume":"340","author":"Akaishi","year":"2020","journal-title":"Journal of neuroimmunology"},{"issue":"2","key":"10.1016\/j.msard.2020.102156_bib0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/sji.12512","article-title":"Immunomodulatory and Immunosuppressive Roles of 1alpha,25(OH)2D3 in Autoimmune Diseases","volume":"85","author":"Alhassan Mohammed","year":"2017","journal-title":"Scandinavian journal of immunology"},{"issue":"9","key":"10.1016\/j.msard.2020.102156_bib0003","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/ard.2007.069831","article-title":"Vitamin D and autoimmunity: new aetiological and therapeutic considerations","volume":"66","author":"Arnson","year":"2007","journal-title":"Annals of the rheumatic diseases"},{"issue":"3","key":"10.1016\/j.msard.2020.102156_bib0004","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","volume":"71","author":"Ascherio","year":"2014","journal-title":"JAMA neurology"},{"issue":"3","key":"10.1016\/j.msard.2020.102156_bib0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458517699791","article-title":"Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study","volume":"24","author":"Asgari","year":"2018","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.msard.2020.102156_bib0006","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000439278","article-title":"Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial","volume":"22","author":"Ashtari","year":"2015","journal-title":"Neuroimmunomodulation"},{"issue":"2","key":"10.1016\/j.msard.2020.102156_bib0007","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cct.2014.10.004","article-title":"The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis","volume":"39","author":"Bhargava","year":"2014","journal-title":"Contemp Clin Trials"},{"issue":"9","key":"10.1016\/j.msard.2020.102156_bib0008","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1 ,25-Dihydroxyvitamin D3 Has a Direct Effect on Naive CD4+ T Cells to Enhance the Development of Th2 Cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.msard.2020.102156_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00888","article-title":"Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis","volume":"9","author":"Borisow","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.msard.2020.102156_bib0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.msard.2019.01.047","article-title":"Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disorders","volume":"30","author":"Brill","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"8","key":"10.1016\/j.msard.2020.102156_bib0011","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/intimm\/dxr045","article-title":"Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling","volume":"23","author":"Bruce","year":"2011","journal-title":"International immunology"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","article-title":"An epidemiological study of neuromyelitis optica in Cuba","volume":"256","author":"Cabrera-Gomez","year":"2009","journal-title":"Journal of neurology"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0013","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/abbi.2000.1765","article-title":"In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3)","volume":"377","author":"Cantorna","year":"2000","journal-title":"Archives of biochemistry and biophysics"},{"issue":"Pt 7","key":"10.1016\/j.msard.2020.102156_bib0014","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/awh486","article-title":"Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis","volume":"128","author":"Cepok","year":"2005","journal-title":"Brain: a journal of neurology"},{"issue":"3","key":"10.1016\/j.msard.2020.102156_bib0015","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","article-title":"Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation","volume":"179","author":"Chen","year":"2007","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"issue":"5","key":"10.1016\/j.msard.2020.102156_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125836","article-title":"Treatment with Vitamin D\/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis","volume":"10","author":"Chiuso-Minicucci","year":"2015","journal-title":"PloS one"},{"issue":"3","key":"10.1016\/j.msard.2020.102156_bib0017","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10072-018-3248-y","article-title":"The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder","volume":"39","author":"Cho","year":"2018","journal-title":"Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"8","key":"10.1016\/j.msard.2020.102156_bib0018","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.4049\/jimmunol.1000588","article-title":"Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects","volume":"185","author":"Correale","year":"2010","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"issue":"1-2","key":"10.1016\/j.msard.2020.102156_bib0019","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jns.2011.06.027","article-title":"Vitamin D-mediated immune regulation in multiple sclerosis","volume":"311","author":"Correale","year":"2011","journal-title":"Journal of the neurological sciences"},{"key":"10.1016\/j.msard.2020.102156_bib0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2016.08.005","article-title":"Vitamin D modulates different IL-17-secreting T cell subsets in multiple sclerosis patients","volume":"299","author":"da Costa","year":"2016","journal-title":"Journal of neuroimmunology"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0021","first-page":"153","article-title":"Vitamin D and systemic lupus erythematous: a review of immunological and clinical aspects","volume":"36","author":"Dall'Ara","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.msard.2020.102156_bib0022","first-page":"697","article-title":"Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential","volume":"7","author":"Dankers","year":"2016","journal-title":"Frontiers in immunology"},{"key":"10.1016\/j.msard.2020.102156_bib0023","doi-asserted-by":"crossref","DOI":"10.1038\/srep45926","article-title":"Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients","volume":"7","author":"Darwish","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.msard.2020.102156_bib0024","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.4049\/jimmunol.166.4.2688","article-title":"Elastase controls the binding of the vitamin D-binding protein (Gc-globulin) to neutrophils: a potential role in the regulation of C5a co-chemotactic activity","volume":"166","author":"DiMartino","year":"2001","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0025","article-title":"High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial","volume":"6","author":"D\u00f6rr","year":"2020","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1016\/j.msard.2020.102156_bib0026","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-13-15","article-title":"Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial","volume":"13","author":"D\u00f6rr","year":"2012","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.msard.2020.102156_bib0027","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/cei.12406","article-title":"Impaired T cell activation and cytokine production by calcitriol-primed human B cells","volume":"178","author":"Drozdenko","year":"2014","journal-title":"Clinical and experimental immunology"},{"key":"10.1016\/j.msard.2020.102156_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/174720","article-title":"Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis","volume":"2015","author":"Etemadifar","year":"2015","journal-title":"Multiple sclerosis international"},{"key":"10.1016\/j.msard.2020.102156_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/638968","article-title":"Follicular Helper CD4+ T Cells in Human Neuroautoimmune Diseases and Their Animal Models","volume":"2015","author":"Fan","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10.1016\/j.msard.2020.102156_bib0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/cns.12071","article-title":"Vitamin D3 induces IDO+ tolerogenic DCs and enhances Treg, reducing the severity of EAE","volume":"19","author":"Farias","year":"2013","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"10.1016\/j.msard.2020.102156_bib0031","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Annals of neurology"},{"issue":"9","key":"10.1016\/j.msard.2020.102156_bib0032","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11910-014-0483-3","article-title":"Neuromyelitis optica spectrum disorders","volume":"14","author":"Flanagan","year":"2014","journal-title":"Current neurology and neuroscience reports"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0033","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1212\/NXI.0000000000000011","article-title":"AQP4 autoantibody assay performance in clinical laboratory service","volume":"1","author":"Fryer","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"10.1016\/j.msard.2020.102156_bib0034","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/WCO.0000000000000694","article-title":"Neuromyelitis optica spectrum disorders: still evolving and broadening","volume":"32","author":"Fujihara","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"10.1016\/j.msard.2020.102156_bib0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrneurol.2016.49","article-title":"Multiple sclerosis: Vitamin D deficiency leads to excessive B-cell responses in multiple sclerosis","volume":"12","author":"Fyfe","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.msard.2020.102156_bib0036","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jocn.2018.11.024","article-title":"Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders","volume":"61","author":"Gao","year":"2019","journal-title":"Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia"},{"issue":"12","key":"10.1016\/j.msard.2020.102156_bib0037","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1177\/1352458518792433","article-title":"Vitamin D-binding protein and multiple sclerosis: Evidence, controversies, and needs","volume":"24","author":"Gauzzi","year":"2018","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.msard.2020.102156_bib0038","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00281-018-0723-8","article-title":"Sex differences in autoimmune disorders of the central nervous system","volume":"41","author":"Gold","year":"2019","journal-title":"Seminars in immunopathology"},{"issue":"52","key":"10.1016\/j.msard.2020.102156_bib0039","doi-asserted-by":"crossref","first-page":"21101","DOI":"10.1073\/pnas.1306072110","article-title":"1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization","volume":"110","author":"Grishkan","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.msard.2020.102156_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2016.03.011","article-title":"Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis","volume":"294","author":"Haas","year":"2016","journal-title":"Journal of neuroimmunology"},{"issue":"7","key":"10.1016\/j.msard.2020.102156_bib0041","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s10072-017-2932-7","article-title":"Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders","volume":"38","author":"Han","year":"2017","journal-title":"Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"3","key":"10.1016\/j.msard.2020.102156_bib0042","first-page":"189","article-title":"Vitamin D prevents endothelial damage induced by increased neutrophil extracellular traps formation in patients with systemic lupus erythematosus","volume":"46","author":"Handono","year":"2014","journal-title":"Acta medica Indonesiana"},{"key":"10.1016\/j.msard.2020.102156_bib0043","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fimmu.2019.00201","article-title":"The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders","volume":"10","author":"H\u00e4usser-Kinzel","year":"2019","journal-title":"Frontiers in immunology"},{"issue":"8","key":"10.1016\/j.msard.2020.102156_bib0044","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/eji.200838216","article-title":"1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells","volume":"38","author":"Heine","year":"2008","journal-title":"European journal of immunology"},{"issue":"2","key":"10.1016\/j.msard.2020.102156_bib0045","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1352458515586084","article-title":"Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica","volume":"22","author":"Hertwig","year":"2016","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"9","key":"10.1016\/j.msard.2020.102156_bib0046","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/archneurol.2009.188","article-title":"Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells","volume":"66","author":"Hinson","year":"2009","journal-title":"Archives of neurology"},{"issue":"5","key":"10.1016\/j.msard.2020.102156_bib0047","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1210\/endo-129-5-2774","article-title":"Transcriptional regulation of the production of the third component of complement (C3) by 1 alpha,25-dihydroxyvitamin D3 in mouse marrow-derived stromal cells (ST2) and primary osteoblastic cells","volume":"129","author":"Hong","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.msard.2020.102156_bib0048","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msard.2017.10.015","article-title":"Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence","volume":"19","author":"Hor","year":"2018","journal-title":"Multiple sclerosis and related disorders"},{"issue":"19","key":"10.1016\/j.msard.2020.102156_bib0049","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1212\/WNL.0000000000004611","article-title":"Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan","volume":"89","author":"Houzen","year":"2017","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.msard.2020.102156_bib0050","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1212\/WNL.0000000000008445","article-title":"Randomized trial of daily high-dose vitamin D(3) in patients with RRMS receiving subcutaneous interferon \u03b2-1a","volume":"93","author":"Hupperts","year":"2019","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2020.102156_bib0051","article-title":"Vitamin D for the management of multiple sclerosis","volume":"9","author":"Jagannath","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.msard.2020.102156_bib0052","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"Journal of neuroinflammation"},{"issue":"3","key":"10.1016\/j.msard.2020.102156_bib0053","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ijms17030273","article-title":"The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives","volume":"17","author":"Jasiak-Zatonska","year":"2016","journal-title":"International journal of molecular sciences"},{"issue":"9","key":"10.1016\/j.msard.2020.102156_bib0054","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.4049\/jimmunol.0803217","article-title":"1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3","volume":"183","author":"Jeffery","year":"2009","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.msard.2020.102156_bib0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2016.03.016","article-title":"Vitamin D level status in Thai neuromyelitis optica patients","volume":"295-296","author":"Jitprapaikulsan","year":"2016","journal-title":"Journal of neuroimmunology"},{"issue":"17","key":"10.1016\/j.msard.2020.102156_bib0056","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/MCB.05020-11","article-title":"1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A","volume":"31","author":"Joshi","year":"2011","journal-title":"Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.msard.2020.102156_bib0057","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.msard.2020.102156_bib0058","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.msard.2017.08.005","article-title":"Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study","volume":"17","author":"Kessler","year":"2017","journal-title":"Multiple sclerosis and related disorders"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0059","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1212\/NXI.0000000000000004","article-title":"Predictors of recurrence following an initial episode of transverse myelitis","volume":"1","author":"Kimbrough","year":"2014","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"issue":"1-2","key":"10.1016\/j.msard.2020.102156_bib0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2011.08.019","article-title":"Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive\/memory Breg ratio during a relapse but not in remission","volume":"239","author":"Knippenberg","year":"2011","journal-title":"Journal of neuroimmunology"},{"issue":"12","key":"10.1016\/j.msard.2020.102156_bib0061","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1177\/1352458511412655","article-title":"Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis","volume":"17","author":"Knippenberg","year":"2011","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"key":"10.1016\/j.msard.2020.102156_bib0062","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2017.00047","article-title":"Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism","volume":"8","author":"Ko\u010dovsk\u00e1","year":"2017","journal-title":"Front Psychiatry"},{"issue":"3","key":"10.1016\/j.msard.2020.102156_bib0063","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri3802","article-title":"Memory B cells","volume":"15","author":"Kurosaki","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"9451","key":"10.1016\/j.msard.2020.102156_bib0064","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.msard.2020.102156_bib0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/B978-0-12-800100-4.00006-4","article-title":"Immunopathogenesis of neuromyelitis optica","volume":"121","author":"Levy","year":"2014","journal-title":"Advances in immunology"},{"key":"10.1016\/j.msard.2020.102156_bib0066","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jneuroim.2014.11.011","article-title":"Association of circulating follicular helper T cells with disease course of NMO spectrum disorders","volume":"278","author":"Li","year":"2015","journal-title":"Journal of neuroimmunology"},{"issue":"9","key":"10.1016\/j.msard.2020.102156_bib0067","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.4049\/jimmunol.140.9.3082","article-title":"Effects of vitamin D3 and IFN-gamma on the synthesis of the second complement component, C2, by a human myeloid leukemia (HL-60) cell line","volume":"140","author":"Littman","year":"1988","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"issue":"146","key":"10.1016\/j.msard.2020.102156_bib0068","doi-asserted-by":"crossref","DOI":"10.3791\/59014","article-title":"Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay","author":"Liu","year":"2019","journal-title":"J Vis Exp"},{"key":"10.1016\/j.msard.2020.102156_bib0069","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jneuroim.2018.10.013","article-title":"Increased expression of the membrane-bound CD40 ligand on peripheral CD4(+) T cells in the acute phase of AQP4-IgG-seropositive neuromyelitis optica spectrum disorders","volume":"325","author":"Liu","year":"2018","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.msard.2020.102156_bib0070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/WCO.0000000000000455","article-title":"Neuromyelitis optica and neuromyelitis optica spectrum disorders","volume":"30","author":"Marignier","year":"2017","journal-title":"Current opinion in neurology"},{"issue":"11","key":"10.1016\/j.msard.2020.102156_bib0071","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1177\/0961203319877255","article-title":"Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience","volume":"28","author":"Mart\u00edn-Nares","year":"2019","journal-title":"Lupus"},{"issue":"23","key":"10.1016\/j.msard.2020.102156_bib0072","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","article-title":"NMO-IgG predicts the outcome of recurrent optic neuritis","volume":"70","author":"Matiello","year":"2008","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.msard.2020.102156_bib0073","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00415-018-9074-6","article-title":"Vitamin D for the treatment of multiple sclerosis: a meta-analysis","volume":"265","author":"McLaughlin","year":"2018","journal-title":"J Neurol"},{"issue":"13","key":"10.1016\/j.msard.2020.102156_bib0074","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1177\/1352458517730131","article-title":"Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders","volume":"24","author":"Mealy","year":"2018","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"3","key":"10.1016\/j.msard.2020.102156_bib0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archneurol.2011.1974","article-title":"Low serum vitamin D levels and recurrent inflammatory spinal cord disease","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0076","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cyto.2013.07.019","article-title":"Post-acute serum eosinophil and neutrophil-associated cytokine\/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - a pilot study","volume":"64","author":"Michael","year":"2013","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.msard.2020.102156_bib0077","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107274","article-title":"Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability","volume":"9","author":"Min","year":"2014","journal-title":"PloS one"},{"key":"10.1016\/j.msard.2020.102156_bib0078","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.12118","article-title":"Immunology of neuromyelitis optica: a T cell-B cell collaboration","volume":"1283","author":"Mitsdoerffer","year":"2013","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"8","key":"10.1016\/j.msard.2020.102156_bib0079","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001866","article-title":"Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study","volume":"12","author":"Mokry","year":"2015","journal-title":"PLoS Med"},{"issue":"13","key":"10.1016\/j.msard.2020.102156_bib0080","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1084\/jem.20130699","article-title":"MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies","volume":"210","author":"Molnarfi","year":"2013","journal-title":"The Journal of experimental medicine"},{"issue":"6","key":"10.1016\/j.msard.2020.102156_bib0081","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/jnnp-2017-317566","article-title":"Worldwide prevalence of neuromyelitis optica spectrum disorders","volume":"89","author":"Mori","year":"2018","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"6","key":"10.1016\/j.msard.2020.102156_bib0082","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/08820139.2011.573041","article-title":"Therapeutic effect of vitamin D3 in multiple sclerosis patients","volume":"40","author":"Mosayebi","year":"2011","journal-title":"Immunol Invest"},{"key":"10.1016\/j.msard.2020.102156_bib0083","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jneuroim.2016.09.018","article-title":"Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNbeta; the SOLARIUM study","volume":"300","author":"Muris","year":"2016","journal-title":"Journal of neuroimmunology"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0084","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.intimp.2015.06.033","article-title":"Vitamin D supplementation up-regulates IL-6 and IL-17A gene expression in multiple sclerosis patients","volume":"28","author":"Naghavi Gargari","year":"2015","journal-title":"International immunopharmacology"},{"key":"10.1016\/j.msard.2020.102156_bib0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.msard.2018.07.025","article-title":"MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder","volume":"25","author":"Narayan","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0086","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.msard.2020.102156_bib0087","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","article-title":"Demographic and clinical features of neuromyelitis optica: A review","volume":"21","author":"Pandit","year":"2015","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"24","key":"10.1016\/j.msard.2020.102156_bib0088","doi-asserted-by":"crossref","first-page":"e2265","DOI":"10.1212\/WNL.0000000000006645","article-title":"Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark","volume":"91","author":"Papp","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2020.102156_bib0089","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.rdc.2017.06.007","article-title":"Neuromyelitis Optica","volume":"43","author":"Patterson","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"issue":"12","key":"10.1016\/j.msard.2020.102156_bib0090","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.autrev.2011.05.002","article-title":"Effects of vitamin D on the peripheral adaptive immune system: a review","volume":"10","author":"Peelen","year":"2011","journal-title":"Autoimmunity reviews"},{"key":"10.1016\/j.msard.2020.102156_bib0091","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.msard.2017.03.014","article-title":"Vitamin D and multiple sclerosis: An update","volume":"14","author":"Pierrot-Deseilligny","year":"2017","journal-title":"Multiple sclerosis and related disorders"},{"issue":"8","key":"10.1016\/j.msard.2020.102156_bib0092","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.4049\/jimmunol.136.8.2734","article-title":"1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production","volume":"136","author":"Provvedini","year":"1986","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"issue":"10","key":"10.1016\/j.msard.2020.102156_bib0093","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.msard.2020.102156_bib0094","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-012-0986-4","article-title":"Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss","volume":"123","author":"Ratelade","year":"2012","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.msard.2020.102156_bib0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/nyas.12440","article-title":"Vitamin D effects on B cell function in autoimmunity","volume":"1317","author":"Rolf","year":"2014","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"3","key":"10.1016\/j.msard.2020.102156_bib0096","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ana.22686","article-title":"Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain","volume":"71","author":"Saadoun","year":"2012","journal-title":"Annals of neurology"},{"key":"10.1016\/j.msard.2020.102156_bib0097","article-title":"Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates","author":"Sepulveda","year":"2017","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"8","key":"10.1016\/j.msard.2020.102156_bib0098","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.molimm.2005.07.023","article-title":"Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1,25(OH)2 vitamin D3","volume":"43","author":"Shah","year":"2006","journal-title":"Molecular immunology"},{"key":"10.1016\/j.msard.2020.102156_bib0099","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jneuroim.2016.09.006","article-title":"Serum 25-hydroxyvitamin D3 is associated with disease status in patients with neuromyelitis optica spectrum disorders in south China","volume":"299","author":"Shan","year":"2016","journal-title":"Journal of neuroimmunology"},{"key":"10.1016\/j.msard.2020.102156_bib0100","article-title":"Association between Sun Exposure, Vitamin D Intake, Serum Vitamin D Level, and Immunoglobulin G Level in Patients with Neuromyelitis Optica Spectrum Disorder","volume":"9","author":"Shaygannejad","year":"2018","journal-title":"Int J Prev Med"},{"issue":"3","key":"10.1016\/j.msard.2020.102156_bib0101","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.yexmp.2017.05.015","article-title":"1,25-Dihydroxyvitamin D3 suppressed experimental autoimmune encephalomyelitis through both immunomodulation and oligodendrocyte maturation","volume":"102","author":"Shirazi","year":"2017","journal-title":"Experimental and molecular pathology"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0103","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","article-title":"Vitamin D and Multiple Sclerosis: A Comprehensive Review","volume":"7","author":"Sintzel","year":"2018","journal-title":"Neurol Ther"},{"key":"10.1016\/j.msard.2020.102156_bib0104","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1742-2094-8-56","article-title":"Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism","volume":"8","author":"Sloka","year":"2011","journal-title":"Journal of neuroinflammation"},{"issue":"12","key":"10.1016\/j.msard.2020.102156_bib0105","doi-asserted-by":"crossref","first-page":"e15235","DOI":"10.1371\/journal.pone.0015235","article-title":"Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis","volume":"5","author":"Smolders","year":"2010","journal-title":"PloS one"},{"issue":"4","key":"10.1016\/j.msard.2020.102156_bib0106","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.0000000000002316","article-title":"Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis","volume":"86","author":"Sotirchos","year":"2016","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2020.102156_bib0108","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.4049\/jimmunol.177.9.6030","article-title":"IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis","volume":"177","author":"Spach","year":"2006","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0109","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11011-011-9266-6","article-title":"Contribution of GPR30 for 1,25 dihydroxyvitamin D(3) protection in EAE","volume":"27","author":"Subramanian","year":"2012","journal-title":"Metabolic brain disease"},{"issue":"12","key":"10.1016\/j.msard.2020.102156_bib0110","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.steroids.2011.06.009","article-title":"1alpha,25-Dihydroxyvitamin D(3) inhibits neutrophil recruitment in hamster model of acute lung injury","volume":"76","author":"Takano","year":"2011","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0111","article-title":"Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro","volume":"4","author":"Takeshita","year":"2016","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"issue":"5","key":"10.1016\/j.msard.2020.102156_bib0112","doi-asserted-by":"crossref","first-page":"R221","DOI":"10.1186\/ar4060","article-title":"Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation","volume":"14","author":"Terrier","year":"2012","journal-title":"Arthritis research & therapy"},{"key":"10.1016\/j.msard.2020.102156_bib0113","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2015.05.022","article-title":"Effect of high dose vitamin D intake on interleukin-17 levels in multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial","volume":"285","author":"Toghianifar","year":"2015","journal-title":"Journal of neuroimmunology"},{"issue":"6","key":"10.1016\/j.msard.2020.102156_bib0114","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3945\/ajcn.111.031070","article-title":"Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis","volume":"95","author":"Tripkovic","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.msard.2020.102156_bib0115","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s10072-015-2229-7","article-title":"Reduced serum vitamin D levels in neuromyelitis optica","volume":"36","author":"Tuzun","year":"2015","journal-title":"Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"12","key":"10.1016\/j.msard.2020.102156_bib0116","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s00415-009-5274-4","article-title":"Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis","volume":"256","author":"Uzawa","year":"2009","journal-title":"Journal of neurology"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0117","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bpa.12097","article-title":"Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications","volume":"24","author":"Uzawa","year":"2014","journal-title":"Brain pathology (Zurich, Switzerland)"},{"key":"10.1016\/j.msard.2020.102156_bib0118","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.msard.2015.12.004","article-title":"T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO)","volume":"6","author":"Vaknin-Dembinsky","year":"2016","journal-title":"Multiple sclerosis and related disorders"},{"issue":"2","key":"10.1016\/j.msard.2020.102156_bib0119","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1212\/NXI.0000000000000317","article-title":"Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study","volume":"4","author":"Valentino","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"10.1016\/j.msard.2020.102156_bib0120","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.ejcn.1601952","article-title":"Multiple sclerosis and vitamin D: an update","volume":"58","author":"VanAmerongen","year":"2004","journal-title":"European journal of clinical nutrition"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0121","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.23651","article-title":"Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter","volume":"72","author":"Varrin-Doyer","year":"2012","journal-title":"Annals of neurology"},{"issue":"10","key":"10.1016\/j.msard.2020.102156_bib0122","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jocn.2011.01.031","article-title":"Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse","volume":"18","author":"Wang","year":"2011","journal-title":"Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia"},{"issue":"48","key":"10.1016\/j.msard.2020.102156_bib0123","doi-asserted-by":"crossref","first-page":"e13100","DOI":"10.1097\/MD.0000000000013100","article-title":"A multi-facet comparative analysis of neuromyelitis optica spectrum disorders in patients with seropositive and seronegative AQP4-IgG","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine"},{"issue":"5-6","key":"10.1016\/j.msard.2020.102156_bib0124","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000464135","article-title":"Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder","volume":"23","author":"Wang","year":"2016","journal-title":"Neuroimmunomodulation"},{"issue":"7","key":"10.1016\/j.msard.2020.102156_bib0125","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis","volume":"65","author":"Waters","year":"2008","journal-title":"Archives of neurology"},{"issue":"4","key":"10.1016\/j.msard.2020.102156_bib0126","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","article-title":"Neuromyelitis Spectrum Disorders","volume":"92","author":"Weinshenker","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.msard.2020.102156_bib0127","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Annals of neurology"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0128","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11914-011-0094-8","article-title":"Vitamin D in the new millennium","volume":"10","author":"Wimalawansa","year":"2012","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"10.1016\/j.msard.2020.102156_bib0129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2020.102156_bib0130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.msard.2020.102156_bib0131","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.msard.2018.12.002","article-title":"Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models","volume":"27","author":"Wu","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"10.1016\/j.msard.2020.102156_bib0132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120515","article-title":"1alpha,25-Dihydroxyvitamin D3 Induces Neutrophil Apoptosis through the p38 MAPK Signaling Pathway in Chronic Obstructive Pulmonary Disease Patients","volume":"10","author":"Yang","year":"2015","journal-title":"PloS one"},{"issue":"2","key":"10.1016\/j.msard.2020.102156_bib0133","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cellimm.2012.10.002","article-title":"Protective role of the vitamin D receptor","volume":"279","author":"Yang","year":"2012","journal-title":"Cellular immunology"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0134","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"Zamvil","year":"2015","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0135","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-016-0355-y","article-title":"Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO\/SD","volume":"4","author":"Zeka","year":"2016","journal-title":"Acta neuropathologica communications"},{"issue":"1","key":"10.1016\/j.msard.2020.102156_bib0136","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/cns.12774","article-title":"Th2 axis-related cytokines in patients with neuromyelitis optica spectrum disorders","volume":"24","author":"Zhang","year":"2018","journal-title":"CNS neuroscience & therapeutics"},{"key":"10.1016\/j.msard.2020.102156_bib0137","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.molimm.2017.09.006","article-title":"1,25(OH)2D3 induces regulatory T cell differentiation by influencing the VDR\/PLC-gamma1\/TGF-beta1\/pathway","volume":"91","author":"Zhou","year":"2017","journal-title":"Molecular immunology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820302327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820302327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:48:35Z","timestamp":1761900515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820302327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":135,"alternative-id":["S2211034820302327"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102156","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Potential Immunoregulatory Roles of Vitamin D in Neuromyelitis Optica Spectrum Disorder","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102156"}}